Search Results - Jean‐François Emile

Refine Results
  1. 1
    Complete remission of critical neurohistiocytosis by vemurafenib

    Complete remission of critical neurohistiocytosis by vemurafenib by Philipp Euskirchen, Julien Haroche, Jean‐François Emile, Ralph Buchert, Staffan Vandersee, Andreas Meisel

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Erdheim–Chester Disease

    Erdheim–Chester Disease by Julien Haroche, Laurent Arnaud, F. Cohen Aubart, B. Hervier, Frédéric Charlotte, Jean‐François Emile, Zahir Amoura

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis

    Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis by Sebastien Héritier, M Jehanne, G Leverger, Jean‐François Emile, Jean‐Claude Alvarez, Julien Haroche, Jean Donadieu

    Published 2015
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    Importance of T Cells, Gamma Interferon, and Tumor Necrosis Factor in Immune Control of the Rapid Grower<i>Mycobacterium abscessus</i>in C57BL/6 Mice

    Importance of T Cells, Gamma Interferon, and Tumor Necrosis Factor in Immune Control of the Rapid Grower<i>Mycobacterium abscessus</i>in C57BL/6 Mice by Martin Rottman, Émilie Catherinot, Patrick Hochedez, Jean‐François Emile, Jean‐Laurent Casanova, Jean‐Louis Gaillard, Claire Soudais

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver

    Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver by Daniel Azoulay, Denis Castaing, Jinane Krissat, Alloua Smail, Guillermo Marín Hargreaves, Antoinette Lemoine, Jean‐François Emile, Henri Bismuth

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    “Silent” presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection

    “Silent” presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection by Mylène Sebagh, Maryline Debette, Didier Samuel, Jean‐François Emile, Bruno Falissard, Valérie Cailliez, Daniel Shouval, Henri Bismuth, M Reynès

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts

    IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts by Martin Rottman, Claire Soudais, Guillaume Vogt, Laurent Rénia, Jean‐François Emile, Hélène Decaluwe, Jean‐Louis Gaillard, Jean‐Laurent Casanova

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Profiling of the Tetraspanin Web of Human Colon Cancer Cells

    Profiling of the Tetraspanin Web of Human Colon Cancer Cells by François Le Naour, Magali André, Céline Greco, Martine Billard, Bernard Sordat, Jean‐François Emile, François Lanza, Claude Boucheix, Eric Rubinstein

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Efficacy of the <scp>MEK</scp> inhibitor cobimetinib for wild‐type <i><scp>BRAF</scp></i> Erdheim‐Chester disease

    Efficacy of the <scp>MEK</scp> inhibitor cobimetinib for wild‐type <i><scp>BRAF</scp></i> Erdheim‐Chester disease by F. Cohen Aubart, Jean‐François Emile, Philippe Maksud, Damien Galanaud, Philippe Cluzel, Neïla Benameur, O. Aumaître, Zahir Amoura, Julien Haroche

    Published 2016
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  10. 10
    MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations

    MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations by Francesco Pegoraro, Fleur Cohen-Aubart, Matthias Papo, Francesco Catamerò, J. Razanamahery, Zahir Amoura, Jean‐François Emile, Augusto Vaglio, Julien Haroche

    Published 2025
    Get full text
    Carta
    Save to List
    Saved in:
  11. 11
    <i>BRAF</i> V600E mutation detected in a case of Rosai-Dorfman disease

    <i>BRAF</i> V600E mutation detected in a case of Rosai-Dorfman disease by Giancarlo Fatobene, Julien Haroche, Zofia Hélias-Rodzwicz, Frédéric Charlotte, Valérie Taly, Aliana Meneses Ferreira, André Abdo, Vanderson Rocha, Jean‐François Emile

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma

    Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma by Katia Lemdani, Nathalie Mignet, Vincent Boudy, Johanne Séguin, Edward Oujagir, Olivia Bawa, Frédérique Peschaud, Jean‐François Emile, Claude Capron, Robert Malafosse

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Histiocytosis and the nervous system: from diagnosis to targeted therapies

    Histiocytosis and the nervous system: from diagnosis to targeted therapies by F. Cohen Aubart, Ahmed Idbaïh, Jean‐François Emile, Zahir Amoura, Omar Abdel‐Wahab, Benjamin H. Durham, Julien Haroche, Eli L. Diamond

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    <i>BRAF</i>Mutation Status in Gastrointestinal Stromal Tumors

    <i>BRAF</i>Mutation Status in Gastrointestinal Stromal Tumors by Isabelle Hostein, Nicolas Faur, Charlotte Primois, Frédérique Boury, Jérome Denard, Jean‐François Emile, Pierre‐Paul Bringuier, Jean–Yves Scoazec, Jean‐Michel Coindre

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Hypervirulence of a Rough Variant of the <i>Mycobacterium abscessus</i> Type Strain

    Hypervirulence of a Rough Variant of the <i>Mycobacterium abscessus</i> Type Strain by É. Catherinot, J. Clarissou, G. Etienne, Fabienne Neulat-Ripoll, Jean‐François Emile, Mamadou Daffé, Christian Perronne, Claire Soudais, Julien Gaillard, Martin Rottman

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Histiocytosis

    Histiocytosis by Jean‐François Emile, F. Cohen Aubart, Matthew Collin, Sylvie Fraitag, Ahmed Idbaïh, Omar Abdel‐Wahab, Barrett J. Rollins, Jean Donadieu, Julien Haroche

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis

    Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis by Mohammed Harb, Tom Abrassart, Laurent Dewispeleare, Pierre Sidon, Naomi Dirckx, Anne‐Laure Trépant, Julie Castiaux, Pierre Heimann, Jean‐François Emile, Hussein Farhat

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells

    EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells by Stéphanie Charrin, François Le Naour, Valérie Labas, Martine Billard, Jean‐Pierre Le Caër, Jean‐François Emile, Marie-Anne Petit, Claude Boucheix, Eric Rubinstein

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Interleukin‐12 Receptor β1 Deficiency in a Patient with Abdominal Tuberculosis

    Interleukin‐12 Receptor β1 Deficiency in a Patient with Abdominal Tuberculosis by Frédéric Altare, Armin Ensser, Adrien Breiman, Janine Reichenbach, Jamila El Baghdadi, Alain Fischer, Jean‐François Emile, Jean‐Louis Gaillard, Edgar Meinl, Jean‐Laurent Casanova

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

    Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer by Etienne Giroux‐Leprieur, Guillaume Herbretau, Coraline Duménil, Catherine Julié, Violaine Giraud, Sylvie Labrune, Jennifer Dumoulin, Julie Tisserand, Jean‐François Emile, Hélène Blons, Thierry Chinet

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: